Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by Sandblaster1980on Jul 11, 2020 8:13pm
105 Views
Post# 31256448

RE:RE:RE:RE:RE:Bullish

RE:RE:RE:RE:RE:Bullish
TheeRook wrote:  FDA EUA  has a low bar of 80% so I think that is already priced in with the last run to $10 , based on the MRI lab tests.  .

  The Nasdaq application too priced in too kept  the share price from falling  too far below $7.
Only thing is if larger orders start coming in.  Which  after some sucessful trial runs should start coming in after FDA EUA approval.

 There are 100 hundreds of test out there  the best current ones  (PCR,  Molecular testing)  take time to do for 100% accuracy.  Newer leading edge tech take 45minutes for a 100% test.  

SONA  at present 96% is a good fast screen based on lab tests that needs to be followed up with a more accurate test. according to guidlines      So SONA has some work to do to bring it up to 100%...  Some may think 96% is good but that means 4 out of 100 could be flase negative and beocme spreaders.  Does not take many to spread Covid 19 as what is happening now in the US.  

willywonka wrote: As a cautious investor, there are two positives that I consider. 1) Awaiting approval of tests 2) application to NASDAQ. If these work out then watch out




Bullboard Posts